This week, members of our team are in Florida for an exciting first-time medical meeting, the Pan American Parkinson’s Disease and Movement Disorders Congress. It brings together a subset of a global group of professionals who research and treat movement disorders, including Parkinson’s.
The Parkinson's Foundation is proud of the work that our scientists have done to advance our understanding of Parkinson’s and to improve lives worldwide.
In December, two reports in the New York Times called attention to the potential link between paraquat, a strong pesticide, and Parkinson’s disease (PD). The pesticide, which has been previously linked to Parkinson’s, is banned in some countries including those where it is manufactured, but not in the US.
What should people with Parkinson’s know about this news?
Earlier this month, Congress approved, and President Obama signed, the Cures Act, formally known as the 21st Century Cures Act. Along with scores of other voluntary health and research organizations, the Parkinson's Foundation applauds this move as one that will confront diseases head-on and accelerate research seeking cures.
Can an aspirin a day treat Parkinson’s disease (PD)? Not exactly, but the idea made headlines a few weeks ago, after scientists discovered that a key ingredient of aspirin might have potential to block the loss of brain cells in neurological diseases like PD and Alzheimer’s.
Who’s talking about sex and Parkinson’s disease? Despite the challenges that some people with Parkinson’s face in regards to sexuality and intimacy (one study showed 87 percent of people with PD experience some sort of issue related to sexuality) the conversation on the topic has been sparse.
The start of 2015 has been noteworthy for those with Parkinson’s disease (PD) as two new therapies — Rytary™ and Duopa™ — were approved by the FDA at the start of January. Both therapies are updates to the gold-standard treatment of A medication used together with levodopa to enhance its effects.